We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Coronavirus-Detecting Breathing Device Could Potentially Give a Diagnosis in Less than One Minute

By LabMedica International staff writers
Posted on 20 Apr 2020
Print article
Image: Coronavirus-detecting breathing device could potentially give a diagnosis in less than one minute (Photo courtesy of Northumbria University)
Image: Coronavirus-detecting breathing device could potentially give a diagnosis in less than one minute (Photo courtesy of Northumbria University)
Researchers from two different parts of the world have developed a new method using a breathing device that could revolutionize the way diseases, such as the newly emerged strain of coronavirus, COVID-19, are diagnosed.

Two Israeli companies, Next-Gen and Scentech Medical, have jointly developed a coronavirus-detecting breathing device based on the breathalyzer machine used by the police for detecting alcohol levels in a person’s blood stream. When the patient breathes into the device, it can distinguish between thousands of gas compounds in the breath and then isolate the ones associated with the coronavirus, enabling a quick and simple diagnosis in less than a minute. In addition to significantly reducing the amount of time to achieve results due to its ability to deliver a diagnosis in minutes, the coronavirus-detecting breathing device can quickly identify and diagnose asymptomatic patients, as well as patients in the early stages of the disease, thus enabling a more efficient quarantine approach. The device is also capable of identifying the virus's genetic 'fingerprint.' – allowing for the detection of the genetic fingerprint of the next potential pandemic-causing virus even before it can do major damage.

Similarly, academics at Northumbria University (Newcastle, England) have developed a new device which enables diagnosis of disease through breath collection. Their new device allows sampling of the lung in a non-invasive way - by patients breathing into it - to retrieve biomarkers, such as DNA, RNA, proteins, and lipids found in the breath that have diagnostic potential for diseases of the lung and beyond. To date, systems that diagnose from breath sampling have not proven to be reliable enough due to contamination, sample loss and variability issues in breath analysis. However, the new device resolves these issues so that the data collected through this pioneering invention closely resembles results from lung samples taken surgically. It is hoped that in the future the technology could be used in the diagnosis of lung diseases as well as other health issues such as diabetes, cancers, liver problems, brain and ageing diseases.

“In the case of coronavirus, temperature monitoring in airports is not sufficient,” said Dr Sterghios Moschos, Associate Professor at Northumbria University, who led the study whilst at Westminster University. “The World Health Organization currently recommends testing nasal swabs, oral swabs and swabs from inside the lungs to avoid missing the infection. That’s why it’s vital that we develop non-invasive, quick and cost-effective tests for diagnosis and screening.”

Related Links:
Northumbria University

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
SARS-CoV-2 RT-PCR Assay
Reliance SARS-CoV-2 RT-PCR Assay Kit

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: The new DxC 500i Clinical Analyzer is an integrated clinical chemistry and immunoassay analyzer (Photo courtesy of Beckman Coulter Diagnostics)

Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability

As global healthcare systems increasingly shift towards networked laboratory operational models to enhance efficiency and patient access, there is a greater need for innovative solutions tailored to the... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Microbiology

view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more

Pathology

view channel
Image: Color-enhanced scanning electron micrograph showing Salmonella Typhimurium (red) invading cultured human cells (Photo courtesy of Rocky Mountain Laboratories, NIAID, NIH)

AI Identifies Drug-Resistant Typhoid-Like Infection from Microscopy Images within Hours

Antimicrobial resistance is becoming a serious global health concern, making many infections increasingly difficult to treat and limiting available treatment options. This escalation in resistance raises... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.